全文获取类型
收费全文 | 2703篇 |
免费 | 144篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 93篇 |
妇产科学 | 107篇 |
基础医学 | 274篇 |
口腔科学 | 15篇 |
临床医学 | 255篇 |
内科学 | 480篇 |
皮肤病学 | 110篇 |
神经病学 | 376篇 |
特种医学 | 179篇 |
外国民族医学 | 22篇 |
外科学 | 329篇 |
综合类 | 33篇 |
一般理论 | 3篇 |
预防医学 | 215篇 |
眼科学 | 15篇 |
药学 | 158篇 |
中国医学 | 5篇 |
肿瘤学 | 175篇 |
出版年
2021年 | 28篇 |
2020年 | 22篇 |
2019年 | 46篇 |
2018年 | 48篇 |
2017年 | 37篇 |
2016年 | 41篇 |
2015年 | 38篇 |
2014年 | 67篇 |
2013年 | 76篇 |
2012年 | 122篇 |
2011年 | 126篇 |
2010年 | 68篇 |
2009年 | 65篇 |
2008年 | 94篇 |
2007年 | 93篇 |
2006年 | 111篇 |
2005年 | 97篇 |
2004年 | 95篇 |
2003年 | 88篇 |
2002年 | 86篇 |
2001年 | 79篇 |
2000年 | 86篇 |
1999年 | 79篇 |
1998年 | 38篇 |
1997年 | 28篇 |
1996年 | 23篇 |
1995年 | 22篇 |
1993年 | 18篇 |
1992年 | 74篇 |
1991年 | 59篇 |
1990年 | 62篇 |
1989年 | 62篇 |
1988年 | 52篇 |
1987年 | 42篇 |
1986年 | 61篇 |
1985年 | 51篇 |
1984年 | 40篇 |
1983年 | 25篇 |
1981年 | 26篇 |
1979年 | 28篇 |
1978年 | 32篇 |
1977年 | 17篇 |
1976年 | 26篇 |
1975年 | 25篇 |
1974年 | 19篇 |
1972年 | 19篇 |
1971年 | 26篇 |
1970年 | 36篇 |
1969年 | 26篇 |
1968年 | 24篇 |
排序方式: 共有2853条查询结果,搜索用时 0 毫秒
61.
H S Margolius R G Geller W De Jong J J Pisano A Sjoerdsma 《Circulation research》1972,31(9):Suppl 2:125-Suppl 2:131
62.
Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. 总被引:13,自引:4,他引:13
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J A Lyon R H Geller J D Haynes J D Chulay J L Weber 《Proceedings of the National Academy of Sciences of the United States of America》1986,83(9):2989-2993
DNA fragments from human malaria parasites were cloned into lambda gt11 to produce a genomic DNA expression library. A pool of monoclonal antibodies (mAbs) recognizing three domains of the 195-kDa major merozoite surface glycoprotein (gp195) reacted with seven clones expressing malaria antigens. mAbs recognizing the 83-kDa product of gp195 reacted with the clones, but mAbs recognizing a glycosylated 45-kDa and a nonglycosylated 45-kDa domain did not. Restriction enzyme mapping revealed that the clones contained overlapping segments encoding about 70% of the gene beginning at the 5' end and ending at an EcoRI restriction enzyme site 3.3 kilobase pairs downstream. The mAbs recognizing the 83-kDa domain reacted differently with the clones, allowing the mapping of three epitopes, one of which was repetitive. Affinity-purified antibodies were selected from immune monkey serum with recombinant expression proteins adsorbed to nitrocellulose filters. When used to probe electrophoretic immunoblots of parasite extracts, these antigen-selected antibodies reacted with specific sets of processed products of gp195, including those associated with the 83- and the nonglycosylated 45-kDa domains. This information, combined with the mAb epitope map, allowed a tentative scheme for processing gp195 from the Camp strain to be proposed. 相似文献
63.
Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis 总被引:15,自引:0,他引:15
Tse HF Reek S Timmermans C Lee KL Geller JC Rodriguez LM Ghaye B Ayers GM Crijns HJ Klein HU Lau CP 《Journal of the American College of Cardiology》2003,42(4):752-758
OBJECTIVES: We sought to evaluate the efficacy and safety of pulmonary vein (PV) isolation using transvenous cryoablation for the treatment of atrial fibrillation (AF). BACKGROUND: Although electrical isolation of PVs with radiofrequency energy for the treatment of AF is feasible, it is associated with a significant risk of PV stenosis. Cryoablation is a new alternative therapy allowing ablation of tissue while preserving its underlying architecture. METHODS: In 52 patients with paroxysmal (n = 45) or persistent (n = 7) AF, PV isolation using the CryoCor cryoablation system (CyroCor Inc., San Diego, California) with a 10F deflectable transvenous catheter was performed as guided by ostial PV potentials. Cryoablation was applied twice at each targeted site (2.5 to 5 min/application). Computed tomography (CT) of the thorax was performed at baseline and at 3 and 12 months to evaluate for PV stenosis. RESULTS: All targeted PVs were completely isolated in 49 (94%) of 52 of patients. Of 152 PVs targeted, 147 (97%) were successfully isolated (mean 3.0 PVs isolated per patient). After a mean period of 12.4 +/- 5.5 months of follow-up, 37 (71%) of 52 patients had no recurrence of AF or were clinically improved, including 29 patients (56%) who had no recurrence of AF with (n = 11) or without the use of anti-arrhythmic drugs. At 3 and 12 months, the CT scan showed no evidence of PV stenosis associated with cryoablation in any patients. CONCLUSIONS: Transvenous catheter cryoablation is an effective method to create PV electrical isolation for the treatment of AF. A clinically satisfactory result can be achieved in 71% of patients with AF, without the risk of PV stenosis. 相似文献
64.
Dabaja-Younis Halima Geller Dan Geffen Yuval Almog Ronit Kassis Imad 《European journal of clinical microbiology & infectious diseases》2021,40(7):1433-1439
European Journal of Clinical Microbiology & Infectious Diseases - The purpose of this study was to estimate the impact of pneumococcal conjugate vaccine-13 (PCV-13) introduction into the... 相似文献
65.
66.
67.
Knatterud GL White C Geller NL Campeau L Forman SA Domanski M Forrester JS Gobel FL Herd JA Hickey A Hoogwerf BJ Hunninghake DB Terrin ML Rosenberg Y 《American heart journal》2003,145(2):262-269
Background Previous studies have suggested that angiographic evidence of disease progression in coronary arteries increases the risk of subsequent coronary clinical events. This study ascertained whether patients enrolled in the Post Coronary Artery Bypass Graft Clinical Trial (POST CABG) who had substantial progression of atherosclerosis in ≥1 saphenous vein grafts (on the basis of assessment of baseline and follow-up angiograms obtained 4-5 years after study entry), but who had not reported clinical symptoms before follow-up angiography, were at a higher risk of subsequent events than patients who did not have substantial progression of atherosclerosis (decrease ≥0.6 mm in lumen diameter at site of greatest change from baseline). Methods All 1351 patients enrolled in the trial underwent baseline angiography; only the 961 patients who had follow-up angiography and no coronary events before the follow-up study were included in this analysis. The clinical center staff contacted patients to ascertain the events that had occurred after follow-up angiography (approximately 3.4 years later). Results Sixty-nine patients had died; 870 patients or relatives were interviewed, and 22 patients could not be contacted. Univariable estimates of relative risk associated with substantial progression ranged from 2.2 (P < .001) for cardiovascular death or nonfatal myocardial infarction to 3.3 (P < .001) for revascularization. Multivariable and univariable estimates of risk were similar. Conclusions The findings provide evidence that patients who had substantial progression of atherosclerosis in vein grafts are at an increased risk for subsequent coronary events and suggest that angiographic changes in vein grafts are appropriate surrogate measures for clinical outcomes. (Am Heart J 2003;145:262-9.) 相似文献
68.
69.